Respiratory Trend Report

Week ending February 7th, 2026

HealthTrackRx
Trend Update

Respiratory virus activity remains elevated nationally, with several pathogens continuing to circulate at moderate to high levels over the past few weeks.

Respiratory Trend Report

Week ending February 7th, 2026

Get Updates

HealthTrackRx
Trend Update

Respiratory virus activity remains elevated nationally, with several pathogens continuing to circulate at moderate to high levels over the past few weeks.

Infection Trends

Influenza A/B: Remains elevated and continues to trend upward, currently at 13.5%, consistent with peak winter activity.
Seasonal Coronaviruses (229E, NL63, HKU1, and OC43): Show a continued upward trend, increasing steadily over the past several weeks and now exceeding 12% positivity.
Rhinovirus/Enterovirus: Continues to be the most frequently detected pathogen at 15.4%, with stable positivity following earlier winter declines.
Respiratory Syncytial Virus (RSV): Positivity remaining stable around 6–7% over recent weeks.
Human Metapneumovirus (hMPV): Activity remains stable, with modest circulation at 3.4%.
Adenovirus, Parainfluenza Viruses (Types 1–4), COVID-19 (SARS-CoV-2), Enterovirus D68 all continue to be stable and low <2%.

Infection Trends

Influenza A/B: Remains elevated and continues to trend upward, currently at 13.5%, consistent with peak winter activity.
Seasonal Coronaviruses (229E, NL63, HKU1, and OC43): Show a continued upward trend, increasing steadily over the past several weeks and now exceeding 12% positivity.
Rhinovirus/Enterovirus: Continues to be the most frequently detected pathogen at 15.4%, with stable positivity following earlier winter declines.
Respiratory Syncytial Virus (RSV): Positivity remaining stable around 6–7% over recent weeks.
Human Metapneumovirus (hMPV): Activity remains stable, with modest circulation at 3.4%.
Adenovirus, Parainfluenza Viruses (Types 1–4), COVID-19 (SARS-CoV-2), Enterovirus D68 all continue to be stable and low <2%.

Seasonal Outlook

Influenza A/B is expected to remain elevated through late winter.
RSV activity is likely to gradually decline over the coming weeks.
Seasonal coronaviruses and hMPV are expected to increase into late winter.
Rhinovirus/Enterovirus will likely persist at baseline levels with potential spring increases.

Seasonal Outlook

Influenza A/B is expected to remain elevated through late winter.
RSV activity is likely to gradually decline over the coming weeks.
Seasonal coronaviruses and hMPV are expected to increase into late winter.
Rhinovirus/Enterovirus will likely persist at baseline levels with potential spring increases.

Trending Up

Influenza A/B
Seasonal Coronaviruses (229E, NL63, HKU1, OC43)

Trending Down

Parainfluenza Viruses (types 1-4)

Remaining Level

Rhinovirus/Enterovirus
Respiratory Syncytial Virus (RSV)
Human Metapneumovirus
COVID-19 Coronavirus (SARS-CoV-2)
Adenovirus
Enterovirus D68

Trending Up

Influenza A/B
Seasonal Coronaviruses (229E, NL63, HKU1, OC43)

Trending Down

Parainfluenza Viruses (types 1-4)

Remaining Level

Rhinovirus/Enterovirus
Respiratory Syncytial Virus (RSV)
Human Metapneumovirus
COVID-19 Coronavirus (SARS-CoV-2)
Adenovirus
Enterovirus D68

7 Day Influenza Virus A/B Map

This report reflects observed trends in HealthTrackRx testing positivity data, does not convey medical advice, and is provided for informational purposes only. Individuals experiencing respiratory symptoms should consult with their healthcare provider.

Download Respiratory Trend Reports [PDF]

View Reports+